Tau phosphorylation in neuronal cell function and dysfunction

Cited by (626)

Items 101–200 of 626

1. Death-Associated Protein Kinase 1 Phosphorylation in Neuronal Cell Death and Neurodegenerative Disease
   Nami Kim, Dongmei Chen, Xiao Zhen Zhou, Tae Ho Lee · 2019 · International Journal of Molecular Sciences
2. Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies
   M. Catarina Silva, Stephen J. Haggarty · 2020 · International Journal of Molecular Sciences
3. Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies
   Kendall B. E. Moore, Ta-Jung Hung, Jessica S. Fortin · 2023 · Drug Discovery Today
4. Neuronal protein trafficking associated with Alzheimer disease
   Bor Luen Tang · 2009 · Cell Adhesion & Migration
5. Pharmacological Inhibition of LIM Kinase Stabilizes Microtubules and Inhibits Neoplastic Growth
   Renaud Prudent, Émilie Vassal‐Stermann, Chi-Hung Nguyen, Catherine Pillet, Anne Martinez, Chloé Prunier, Caroline Barette, Emmanuelle Soleilhac, Odile Filhol, Anne Béghin et al. · 2012 · Cancer Research
6. A combination of an iron chelator with an antioxidant effectively diminishes the dendritic loss, tau-hyperphosphorylation, amyloids-β accumulation and brain mitochondrial dynamic disruption in rats with chronic iron-overload
   Jirapas Sripetchwandee, Suwakon Wongjaikam, Warunsorn Krintratun, Nipon Chattipakorn, Siriporn Chaisin Chattipakorn · 2016 · Neuroscience
7. An Insight into Cellular and Molecular Mechanisms Underlying the Pathogenesis of Neurodegeneration in Alzheimer’s Disease
   Yashumati Ratan, Aishwarya Rajput, Sushmita Maleysm, Aaushi Pareek, Vivek Kumar Jain, Ashutosh Pareek, Ranjeet Kaur, Gurjit Singh · 2023 · Biomedicines
8. CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls
   Megan K. Herbert, Jorine M. Eeftens, Marjolein B. Aerts, Rianne A.J. Esselink, Bastiaan R. Bloem, H. Bea Kuiperij, Marcel M. Verbeek · 2013 · Parkinsonism & Related Disorders
9. Distinguishing normal brain aging from the development of Alzheimer's disease: inflammation, insulin signaling and cognition
   Paul Denver, Paula L. McClean · 2018 · Neural Regeneration Research
10. Protein kinases in neurodegenerative diseases: current understandings and implications for drug discovery
    Wu, Xiaolei, Yang, Zhangzhong, Zou, Jinjun, Gao, Huile, Shao, Zhenhua, Li, Chuanzhou, Lei, Peng · 2025 · Signal Transduction and Targeted Therapy
11. An okadaic acid-induced model of tauopathy and cognitive deficiency
    Zhang Zhang, James W. Simpkins · 2010 · Brain Research
12. Amyloid β-Mediated Cell Death of Cultured Hippocampal Neurons Reveals Extensive Tau Fragmentation without Increased Full-length Tau Phosphorylation
    Jack R. Reifert, DeeAnn Hartung-Cranston, Stuart C. Feinstein · 2011 · Journal of Biological Chemistry
13. Perinatal exposure to lead (Pb) promotes Tau phosphorylation in the rat brain in a GSK-3β and CDK5 dependent manner: Relevance to neurological disorders
    Magdalena Gąssowska-Dobrowolska, Irena Baranowska‐Bosiacka, Joanna Moczydłowska, Maciej Tarnowski, Anna Pilutin, Izabela Gutowska, Lidia Strużyńska, Dariusz Chlubek, Agata Adamczyk · 2016 · Toxicology
14. Okadaic acid induces tau phosphorylation in SH-SY5Y cells in an estrogen-preventable manner
    Zhang Zhang, James W. Simpkins · 2010 · Brain Research
15. Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies
    Anuradha Venkatramani, Dulal Panda · 2019 · International Journal of Biological Macromolecules
16. Low-complexity domain of U1-70K modulates phase separation and aggregation through distinctive basic-acidic motifs
    Song Xue, Rui Gong, Fanqi He, LI Yan-qin, Yunjia Wang, Tianwei Tan, Shizhong Luo · 2019 · Science Advances
17. Dysregulation of Protein Phosphorylation/Dephosphorylation in Alzheimer′s Disease: A Therapeutic Target
    Cheng‐Xin Gong, Fei Liu, Inge Grundke, Khalid Iqbal · 2006 · BioMed Research International
18. Apoptosis Signal Regulating Kinase 1 (ASK1): Potential as a Therapeutic Target for Alzheimer’s Disease
    Juhyun Song, Kyung Hee Park, Won Taek Lee, Jong Eun Lee · 2014 · International Journal of Molecular Sciences
19. Emerging paradigms in nanotechnology for imaging and treatment of cerebral ischemia
    Sathyasivam Kaviarasi, Eiji Yuba, Atsushi Harada, Uma Maheswari Krishnan · 2019 · Journal of Controlled Release
20. Alzheimer's Disease: Recent Advances and Future Perspectives
    Kiren K. Ubhi, Eliezer Masliah · 2012 · Journal of Alzheimer s Disease
21. Neuronally derived extracellular vesicles: an emerging tool for understanding Alzheimer’s disease
    Luke S. Watson, Eric Daniel Hamlett, Tyler D. Stone, Catrina Sims‐Robinson · 2019 · Molecular Neurodegeneration
22. Amyloid Beta and Tau Proteins as Therapeutic Targets for Alzheimer’s Disease Treatment: Rethinking the Current Strategy
    Siddhartha Mondragón‐Rodríguez, George L. Perry, Xiongwei Zhu, Jannic Boehm · 2012 · International Journal of Alzheimer s Disease
23. Inflammasome activation in traumatic brain injury and Alzheimer's disease
    Nathan H. Johnson, Juan Pablo de Rivero Vaccari, Helen M. Bramlett, Robert W. Keane, W. Dalton Dietrich · 2022 · Translational research
24. Endogenous Aβ causes cell death via early tau hyperphosphorylation
    Giuseppina Amadoro, Veronica Corsetti, Maria Teresa Ciotti, Fulvio Florenzano, Simona Capsoni, G. Amato, Pietro Calissano · 2009 · Neurobiology of Aging
25. Phosphorylated tau potentiates Aβ-induced mitochondrial damage in mature neurons
    Rodrigo A. Quintanilla, Rommy von Bernhardi M., Juan Alejandro Godoy, Nibaldo C. Inestrosa, Gail V.W. Johnson · 2014 · Neurobiology of Disease
26. Hyperglycemia-Induced Tau Cleavage in vitro and in vivo: A Possible Link Between Diabetes and Alzheimer's Disease
    Bhumsoo Kim, Carey Backus, SangSu Oh, Eva L. Feldman · 2013 · Journal of Alzheimer s Disease
27. Isomerase Pin1 Stimulates Dephosphorylation of Tau Protein at Cyclin-dependent Kinase (Cdk5)-dependent Alzheimer Phosphorylation Sites
    Taeko Kimura, Koji Tsutsumi, Masato Taoka, Taro Saito, Masami Masuda‐Suzukake, Koichi Ishiguro, Florian Plattner, Takafumi Uchida, Toshiaki Isobe, Masato Hasegawa et al. · 2013 · Journal of Biological Chemistry
28. Selective α7 nicotinic acetylcholine receptor activation regulates glycogen synthase kinase3β and decreases tau phosphorylation in vivo
    Robert S. Bitner, Arthur L. Nikkel, Stella Markosyan, Stephani L. Otte, Pamela S. Puttfarcken, Murali Gopalakrishnan · 2009 · Brain Research
29. Fasciculation and elongation protein zeta-1 (FEZ1) participates in the polarization of hippocampal neuron by controlling the mitochondrial motility
    Junko Ikuta, Andrés Daniel Maturana, Toshitsugu Fujita, Toshihide Okajima, Kenji Tatematsu, Katsuyuki Tanizawa, Shun’ichi Kuroda · 2006 · Biochemical and Biophysical Research Communications
30. Protective effects of ginsenoside Rd against okadaic acid-induced neurotoxicity in vivo and in vitro
    Ling Li, Juanfang Liu, Xiaodong Yan, Kefeng Qin, Ming Shi, Lin Tian, Yi Zhu, Tao Kang, Gang Zhao · 2011 · Journal of Ethnopharmacology
31. Transglutaminase 2 in neurodegenerative disorders
    Qingmin Ruan · 2006 · Frontiers in bioscience
32. 14-3-3 Proteins and regulation of cytoskeleton
    Nikolai N. Sluchanko, Nikolai B. Gusev · 2010 · Biochemistry (Moscow)
33. Deferiprone Reduces Amyloid-β and Tau Phosphorylation Levels but not Reactive Oxygen Species Generation in Hippocampus of Rabbits Fed a Cholesterol-Enriched Diet
    Jaya R.P. Prasanthi, Matthew Schrag, Bhanu Dasari, Gurdeep Marwarha, April Dickson, Wolff M. Kirsch, Othman Ghribi · 2012 · Journal of Alzheimer s Disease
34. Extracellular α-Synuclein Leads to Microtubule Destabilization via GSK-3β-Dependent Tau Phosphorylation in PC12 Cells
    Magdalena Gąssowska-Dobrowolska, Grzegorz Arkadiusz Czapski, Beata Pająk, Magdalena Cieślik, Anna M. Lenkiewicz, Agata Adamczyk · 2014 · PLoS ONE
35. Carbon Dots for Intracellular Sensing
    Fengming Lin, Chenyang Jia, Fu‐Gen Wu · 2022 · Small Structures
36. Tau Phosphorylation, Molecular Chaperones, and Ubiquitin E3 Ligase: Clinical Relevance in Alzheimer's Disease
    Pravir Kumar, Niraj Kumar Jha, Saurabh Kumar Jha, Karunya Ramani, Rashmi K. Ambasta · 2014 · Journal of Alzheimer s Disease
37. Mitochondria dynamism: of shape, transport and cell migration
    André Ferreira da Silva, Francesca Romana Mariotti, Valdemar Máximo, Silvia Campello · 2014 · Cellular and Molecular Life Sciences
38. Bioenergy sensing in the brain
    Stephen Amato, Heng‐Ye Man · 2011 · Cell Cycle
39. Manganese Induces Tau Hyperphosphorylation through the Activation of ERK MAPK Pathway in PC12 Cells
    Tongjian Cai, Honglei Che, Ting Shan Yao, Yaoming Chen, Chuanshu Huang, Wenbin Zhang, Kejun Du, Jianbin Zhang, Yunxin Cao, Jingyuan Chen et al. · 2010 · Toxicological Sciences
40. HDAC 2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease
    Laura J. Mahady, M. Nadeem, Michael H. Malek‐Ahmadi, K. Chen, Sylvia E. Perez, Elliott Jay Mufson · 2018 · Neuropathology and Applied Neurobiology
41. Recent Advances of Degradation Technologies Based on PROTAC Mechanism
    Mingchao Xiao, Jiaojiao Zhao, Qiang Wang, Jia Liu, Leina Ma · 2022 · Biomolecules
42. Role of melatonin in Alzheimer’s disease: From preclinical studies to novel melatonin-based therapies
    Jaydeep Roy, K. Y. Wong, Luca Aquili, Md. Sahab Uddin, Boon Chin Heng, George Lim Tipoe, Kah-Hui Wong, Man‐Lung Fung, Lee Wei Lim · 2022 · Frontiers in Neuroendocrinology
43. Anti-dementia Activity of Nobiletin, a Citrus Flavonoid: A Review of Animal Studies
    Akira Nakajima, Yasushi Ohizumi, Kiyofumi Yamada · 2014 · Clinical Psychopharmacology and Neuroscience
44. Design and Synthesis of a Library of Lead-Like 2,4-Bisheterocyclic Substituted Thiophenes as Selective Dyrk/Clk Inhibitors
    Christian Schmitt, Dagmar Kail, Marica Mariano, Martin Empting, Nadja Weber, Tamara Paul, Rolf W. Hartmann, Matthias Engel · 2014 · PLoS ONE
45. Tauopathy and neurodegeneration: A role for stress
    Jorge A. Sierra-Fonseca, Kristin L. Gosselink · 2018 · Neurobiology of Stress
46. Microtubule‐associated protein tau in human prostate cancer cells: Isoforms, phosphorylation, and interactions
    Skye Souter, Gloria S. Lee · 2009 · Journal of Cellular Biochemistry
47. Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates
    Russell, Claire L., Mitra, Vikram, Hansson, Karl, Blennow, Kaj, Gobom, Johan, Zetterberg, Henrik, Hiltunen, Mikko, Ward, Malcolm, Pike, Ian · 2016 · Journal of Alzheimer's Disease
48. Anesthesia and the Old Brain
    Junxia X. Tang, Maryellen Fazen Eckenhoff, Roderic G. Eckenhoff · 2010 · Anesthesia & Analgesia
49. Standardized Extract of Bacopa monniera Attenuates Okadaic Acid Induced Memory Dysfunction in Rats: Effect on Nrf2 Pathway
    Subhash Dwivedi, Rajasekar Nagarajan, Kashif Hanif, Hefazat Husain Siddiqui, Chandishwar Nath, Rakesh Shukla · 2013 · Evidence-based Complementary and Alternative Medicine
50. Small Molecule Adenosine 5′-Monophosphate Activated Protein Kinase (AMPK) Modulators and Human Diseases
    Sandeep Rana, Elizabeth C. Blowers, Amarnath Natarajan · 2014 · Journal of Medicinal Chemistry
51. Insulin Resistance Prevents AMPK-induced Tau Dephosphorylation through Akt-mediated Increase in AMPKSer-485 Phosphorylation
    Bhumsoo Kim, Claudia Figueroa‐Romero, Crystal M. Pacut, Carey Backus, Eva L. Feldman · 2015 · Journal of Biological Chemistry
52. The neuron‐specific isoform of glycogen synthase kinase‐3β is required for axon growth
    Zafira Castaño, Phillip R. Gordon‐Weeks, Robert M. Kypta · 2010 · Journal of Neurochemistry
53. Cranial irradiation significantly reduces beta amyloid plaques in the brain and improves cognition in a murine model of Alzheimer’s Disease (AD)
    Brian Marples, Mackenzie C. McGee, Sean P. Callan, Scott E. Bowen, Bryan J. Thibodeau, Daniel B. Michael, George David Wilson, Michael E. Maddens, James Fontanesi, Alvaro A. Martinez · 2015 · Radiotherapy and Oncology
54. Targeting Cdk5 Activity in Neuronal Degeneration and Regeneration
    Jyotshnabala Kanungo, Yali Zheng, Niranjana D. Amin, Harish C. Pant · 2009 · Cellular and Molecular Neurobiology
55. Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease
    Najiba Mammadova, Corey M. Summers, Robyn Kokemuller, Qing He, Shaowei Ding, Thierry Baron, Chenxu Yu, Rudy J. Valentine, Donald S. Sakaguchi, Anumantha G. Kanthasamy et al. · 2018 · Neurobiology of Disease
56. Melatonin directly binds and inhibits death‐associated protein kinase 1 function in Alzheimer’s disease
    Dongmei Chen, Yingxue Mei, Nami Kim, Guihua Lan, Chen‐Ling Gan, Fei Fan, Tao Zhang, Yongfang Xia, Long Wang, Chun Lin et al. · 2020 · Journal of Pineal Research
57. Differentiation of SH-SY5Y neuroblastoma cells using retinoic acid and BDNF: a model for neuronal and synaptic differentiation in neurodegeneration
    Imogen L. Targett, Lucy A. Crompton, Myra E. Conway, Tim J. Craig · 2024 · In vitro Cellular & Developmental Biology-Animal
58. Interaction of metal ions with tau protein. The case for a metal-mediated tau aggregation
    Soha Ahmadi, Shaolong Zhu, Renu Sharma, Derek J. Wilson, Heinz‐Bernhard Kraatz · 2019 · Journal of Inorganic Biochemistry
59. Erythropoietin plus insulin‐like growth factor‐I protects against neuronal damage in a murine model of human immunodeficiency virus‐associated neurocognitive disorders
    Yeon‐Joo Kang, Murat H. Digicaylioglu, Rossella Russo, Marcus Kaul, Cristian L. Achim, Lauren Fletcher, Eliezer Masliah, Stuart A. Lipton · 2010 · Annals of Neurology
60. Molecular mechanism of prion‐like tau‐induced neurodegeneration
    Alonso, Alejandra D., Beharry, Cindy, Corbo, Christopher P., Cohen, Leah S. · 2016 · Alzheimer's & Dementia
61. Serum- and Glucocorticoid-Inducible Kinase 1 (SGK1) Increases Neurite Formation through Microtubule Depolymerization by SGK1 and by SGK1 Phosphorylation of tau
    Yang, Ying C., Lin, Cheng H., Lee, Eminy H. Y. · 2006 · Molecular and Cellular Biology
62. The Role and Pathogenesis of Tau Protein in Alzheimer’s Disease
    Xiaoyue Hong, Linshu Huang, Fang Lei, Li Tian, Yi Luo, Mengliu Zeng, Zhuo Wang · 2025 · Biomolecules
63. Xanthoceraside attenuates tau hyperphosphorylation and cognitive deficits in intracerebroventricular-streptozotocin injected rats
    Peng Liu, Libo Zou, Li-Hua Wang, Qing Jiao, Tianyan Chi, Xuefei Ji, Ge Jin · 2013 · Psychopharmacology
64. Tau Phosphorylation in Female Neurodegeneration: Role of Estrogens, Progesterone, and Prolactin
    Daniel Muñoz-Mayorga, Christian Guerra‐Araiza, Luz Torner, Teresa Morales · 2018 · Frontiers in Endocrinology
65. Proteolipid protein–deficient myelin promotes axonal mitochondrial dysfunction via altered metabolic coupling
    Xinghua Yin, Grahame J. Kidd, Nobuhiko Ohno, Guy A Perkins, Mark H. Ellisman, Chinthasagar Bastian, Sylvain Brunet, Selva Baltan, Bruce D. Trapp · 2016 · The Journal of Cell Biology
66. Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer’s disease models
    Huiming Zhang, Xiaojuan Wang, Pu Xu, Xuefei Ji, Tianyan Chi, Peng Liu, Libo Zou · 2020 · The Journal of Physiological Sciences
67. A critical review of radiotracers in the positron emission tomography imaging of traumatic brain injury: FDG, tau, and amyloid imaging in mild traumatic brain injury and chronic traumatic encephalopathy
    Cyrus Ayubcha, Mona-Elisabeth R. Revheim, Andrew B. Newberg, Mateen C. Moghbel, Chaitanya Rojulpote, Thomas J. Werner, Abass A. Alavi · 2020 · European Journal of Nuclear Medicine and Molecular Imaging
68. The microtubule cytoskeleton: An old validated target for novel therapeutic drugs
    Laurence Lafanéchère · 2022 · Frontiers in Pharmacology
69. Systems biology of neurodegenerative diseases
    Levi Benjamin Wood, Ashley R. Winslow, Samantha Dale Strasser · 2015 · Integrative Biology
70. Neuroprotective Effects against POCD by Photobiomodulation: Evidence from Assembly/Disassembly of the Cytoskeleton
    Ann D. Liebert, Roberta T Chow, Brian T. Bicknell, Euahna Varigos · 2016 · Journal of Experimental Neuroscience
71. Tau Mediated Neurodegeneration: An Insight into Alzheimer’s Disease Pathology
    Magisetty Obulesu, R. Venu, R. Somashekhar · 2011 · Neurochemical Research
72. Amyloid β1-42 (Aβ1-42) Induces the CDK2-Mediated Phosphorylation of Tau through the Activation of the mTORC1 Signaling Pathway While Promoting Neuronal Cell Death
    Ki Hoon Lee, Sei‐Jung Lee, Hyun Jik Lee, Gee Euhn Choi, Young Hyun Jung, Dah Ihm Kim, Amr Ahmed Gabr, Jung Min Ryu, Ho Jae Han · 2017 · Frontiers in Molecular Neuroscience
73. Probable Participation of 14-3-3 in Tau Protein Oligomerization and Aggregation
    Nikolai N. Sluchanko, Nikolai B. Gusev · 2011 · Journal of Alzheimer s Disease
74. Chronic oxycodone induces axonal degeneration in rat brain
    Ruping Fan, Lisa M. Schrott, Thomas Arnold, Stephen Snelling, Meghana Rao, Derrel D. Graham, Angela Pettit Cornelius, Nadejda L. Korneeva · 2018 · BMC Neuroscience
75. Brain diabetic neurodegeneration segregates with low intrinsic aerobic capacity
    Joungil Choi, Krish Chandrasekaran, Tyler G. Demarest, Tibor Kristián, Su Xu, Kadambari Vijaykumar, K.G. Dsouza, Nathan Qi, Paul Yarowsky, Rao Gallipoli et al. · 2014 · Annals of Clinical and Translational Neurology
76. Hsp70 ATPase Modulators as Therapeutics for Alzheimer's and other Neurodegenerative Diseases.
    Umesh K. Jinwal, John Koren, John C. O’Leary, Jeffrey R. Jones, Jose Francisco Abisambra, Chad A. Dickey · 2010 · PubMed
77. Wnt5a evokes cortical axon outgrowth and repulsive guidance by tau mediated reorganization of dynamic microtubules
    Li Li, Thomas Fothergill, B. Ian Hutchins, Erik W. Dent, Katherine Kalil · 2013 · Developmental Neurobiology
78. Reduction of Phosphorylated Tau during Memantine Treatment of Alzheimer’s Disease
    M. Degerman Gunnarsson, Lena Kilander, Hans Basun, Lars Lannfelt · 2007 · Dementia and Geriatric Cognitive Disorders
79. ERK activation induced by selenium treatment significantly downregulates β/γ-secretase activity and Tau phosphorylation in the transgenic rat overexpressing human selenoprotein M
    Hwang · 2009 · International Journal of Molecular Medicine
80. The P2X7 receptor: a new therapeutic target in Alzheimer’s disease
    Péter Illés, Patrizia Rubini, Lumei Huang, Yong Tang · 2019 · Expert Opinion on Therapeutic Targets
81. Abnormal tau phosphorylation in primary progressive multiple sclerosis
    Jane Marian Anderson, Rickie Patani, Richard Reynolds, Richard S. Nicholas, Alastair Compston, Maria Grazia Spillantini, Siddharthan Chandran · 2010 · Acta Neuropathologica
82. Production of nerve growth factor by β‐amyloid‐stimulated astrocytes induces p75NTR‐dependent tau hyperphosphorylation in cultured hippocampal neurons
    Estefanía T. Sáez, Mariana Pehar, Marcelo R. Vargas, Luis Barbeito, Ricardo Benjamin Maccioni · 2006 · Journal of Neuroscience Research
83. Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease
    Mirjana Babić Leko, Dubravka Švob Štrac, Dorotea Mück‐Šeler, Nela Pivac, Gabrijela Stanić, Patrick R. Hof, Goran Šimić · 2014 · Croatian Medical Journal
84. Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co–crystal structure
    Yannick J. Esvan, Waël Zeinyeh, Thibaut Boibessot, Lionel Nauton, Vincent Théry, Stefan Knapp, A. Chaikuad, Nadège Loaëc, Laurent Meijer, Fabrice Anizon et al. · 2016 · European Journal of Medicinal Chemistry
85. Tau pathology and neurochemical changes associated with memory dysfunction in an optimised murine model of global cerebral ischaemia - A potential model for vascular dementia?
    Sabah Khan, Nadira Y. Yuldasheva, Trevor F.C. Batten, Alasdair R. Pickles, Katherine A. B. Kellett, Sikha Saha · 2018 · Neurochemistry International
86. A silver lining for 24-hydroxycholesterol in Alzheimer's disease: The involvement of the neuroprotective enzyme sirtuin 1
    Gabriella Testa, Erica Staurenghi, Serena Giannelli, Simona Gargiulo, Michela Guglielmotto, Massimo Tabaton, Elena Tamagno, Paola Gamba, Gabriella Leonarduzzi · 2018 · Redox Biology
87. Beneficial Effect of Genistein on Diabetes-Induced Brain Damage in the ob/ob Mouse Model
    Rongzi Li, Xiao-Wen Ding, Thangiah Geetha, Layla Al‐Nakkash, Tom L. Broderick, Jeganathan Ramesh Babu · 2020 · Drug Design Development and Therapy
88. Neurodegeneration and sport
    Davis, Gavin A., Castellani, Rudolph J., McCrory, Paul · 2015 · Neurosurgery
89. Mechanistic roles for altered O-GlcNAcylation in neurodegenerative disorders
    Aaron T. Balana, Matthew R. Pratt · 2021 · Biochemical Journal
90. Genetic Ablation of Tau Mitigates Cognitive Impairment Induced by Type 1 Diabetes
    Serena Abbondante, David Baglietto‐Vargas, Carlos J. Rodríguez‐Ortiz, Tatiana Estrada-Hernandez, Rodrigo Medeiros, Frank M. LaFerla · 2014 · American Journal Of Pathology
91. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies
    Norbert Žilka, Miroslava Korenova, Michal Novák · 2009 · Acta Neuropathologica
92. Multi-Vitamin B Supplementation Reverses Hypoxia-Induced Tau Hyperphosphorylation and Improves Memory Function in Adult Mice
    Lixia Yu, Yuan Chen, Wei‐Guang Wang, Zhong-hai Xiao, Yan Hong · 2016 · Journal of Alzheimer s Disease
93. Alterations in Tau Protein Level and Phosphorylation State in the Brain of the Autistic-Like Rats Induced by Prenatal Exposure to Valproic Acid
    Magdalena Gąssowska-Dobrowolska, Agnieszka Kolasa, Magdalena Cieślik, Agnieszka Dominiak, Kristina Friedland, Agata Adamczyk · 2021 · International Journal of Molecular Sciences
94. Tau and Tauopathies
    M Robert, Pavagada Sivasankara Mathuranath · 2007 · Neurology India
95. Phosphorylation and inactivation of glycogen synthase kinase-3 by soluble kit ligand in mouse oocytes during early follicular development
    Lian Liu, Rajareddy Singareddy, Pradeep Reddy, Krishna Jagarlamudi, Chun Du, Yan Shen, Yongzhi Guo, Karin Boman, Eva Lundin, Ulrika Ottander et al. · 2007 · Journal of Molecular Endocrinology
96. α-Synuclein, Lrrk2 and Their Interplay In Parkinson‘s Disease
    Guoxiang Liu, Leonardo Aliaga, Huaibin Cai · 2012 · Future Neurology
97. Phosphorylation of more than one site is required for tight interaction of human tau protein with 14‐3‐3ζ
    Nikolai N. Sluchanko, Alim S. Seit‐Nebi, Nikolai B. Gusev · 2009 · FEBS Letters
98. Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?
    Varda Shoshan‐Barmatz, Uttpal Anand, Edna Nahon Crystal, Marta Di Carlo, Anna Shteinfer‐Kuzmine · 2021 · Frontiers in Physiology
99. miR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer’s Disease
    Long Wang, Xindong Shui, Yingxue Mei, Yongfang Xia, Guihua Lan, Li Hu, Mi Zhang, Chen‐Ling Gan, Ruomeng Li, Yuan Tian et al. · 2022 · International Journal of Molecular Sciences
100. Pharmacological effects of natural medicine ginsenosides against Alzheimer’s disease
     Zhikun Shi, Hongyu Chen, Xu Zhou, Wei Yang, Yang Lin · 2022 · Frontiers in Pharmacology